Ruti Aga: The Six-Year Ban Came From a Prescription Pad, Not a Stopwatch

10 September. On that date Ruti Aga's clock stopped, and it stopped for six years. The sanction document lists a prohibited substance, lists tampering, lists a prescription. It does not list the one thing I look for first — who the name is, and where the name came from.

I have had a habit since 2026. I was in Barishal writing up cricket league results while the Facebook pages next door were out-reading our print desk, so I took a pay cut, moved to a Dhaka digital desk's Bangla vertical, and claimed the women's football beat that four colleagues had turned down. The first day required a spreadsheet: 63 names, spellings, pronunciations, districts, clubs. I still update it before every broadcast. Person in the left column, number in the right. Ruti Aga's name is not in that file, because the file is football's. The rule is the same. Name first, number second, cause last.

The number here is easy — six. The cause is hard.

The cause begins with a race whose name I do not have either. In March she won a half marathon in China. The time was not published, at least not in the material I can work from. There was no broadcast. There is no course profile. That race is the final nobody streamed, and going looking for it I found a future in which a career ends because of a prescription pad held by a family member.

The pad story is implausible enough to be true. The person who wrote it is not a doctor, holds no medical registration, and is a relative. In response he said he had used an old pad from a former workplace. The clinic he named denied it flatly — no such pad, no such person. That denial is what turns a doping case into a documents case.

The career was stopped by paper, not by a stopwatch. That is the only genuinely new fact in this affair, and it will not appear in a headline.

Now place the name properly. Ruti Aga is an Ethiopian marathoner, 32 years old. She won the 2026 Tokyo Marathon. She has three runner-up finishes across the World Marathon Majors. That is not biography, it is classification. One Major win plus three Major second places puts her somewhere in the global top 15 to 25 of her generation: consistent, bankable, podium-adjacent, never the face the circuit was built around.

In road racing that gap is a money gap. There is no league, no weekly broadcast, no squad salary. Income arrives from three places — appearance fees, podium bonuses, and, rarely, a shoe contract. A Major winner is rich by the standards of Bangladeshi athletics, but an athlete below the global star band has no team doctor, no physio list, nobody to file a therapeutic use exemption. She has a coach, an agent, and a family.

The Ethiopian marathon pipeline is something I have read on paper, never watched live. In the altitude camps of the Addis Ababa, Sululta and Asella belt there is a personal coach, and an agent holds the race calendar. The athlete does the athleticism. Nobody does the rest. That gap sits at the centre of this case.

From Bangladesh the gap looks familiar. Athletics here means one name — Imranur Rahman's indoor 60m gold, the Paris wildcard. He is England-based and trains in England, and our headlines turn him into proof of a domestic system. During the 2026 World Cup I worked the 3 a.m. studio shift in Russia, 32 matches and 64 preview scripts, and noticed the desk had budgeted zero minutes for the women's game. In the gaps I cut 60-second explainers on my phone. One, on Kalsindur, did 250,000 views, more than any of my previews. The excuse that there was no audience was false.

That same desk will file Ruti Aga in two paragraphs. A foreign athlete banned, fine, run it. Who wrote the prescription, why, who checked it — those questions do not reach our pages, because nobody asks them of our own sports economy.

The substance. Methylprednisolone is a glucocorticoid. Its job is to reduce inflammation. It is not a blood booster, not an anabolic steroid, not EPO. On the WADA prohibited list, glucocorticoids are banned in competition, by injection, oral or rectal route. Out of competition they are not prohibited, only declared.

That single line holds the entire case. She was caught by a calendar, not by a drug.

Knee pain in a marathoner is ordinary — patellofemoral loading over 42 kilometres does that. A corticosteroid in the knee of a 32-year-old runner is ordinary medicine too. The drug does not build a marathoner. It reduces inflammation so she can keep training or stand on a start line. The performance benefit is marginal, and the evidence base for the in-competition prohibition of glucocorticoids has been seriously questioned within sports pharmacology.

So what is the sentence for? Time. If the injection was given in the days around the race — and because glucocorticoids are prohibited only in competition, timing is everything — then a legitimate therapy becomes an automatic anti-doping rule violation without a valid TUE. No detective story. Just a missing administrative document.

A TUE is an administrative product. Forms, deadlines, a committee, a prescribing doctor with a licence number. For an athlete with a team doctor it is routine. For an athlete without one it is impossible. Aga was in the second group, and her medical channel was family-based: the cheapest staff available, and the most expensive mistake available.

Then came the document. Not a doctor, no registration, a relative. An old pad from a former workplace, denied by the clinic. This is where the case changes direction. Presence of a prohibited substance attracts one length of sanction; a false document attracts a longer one. Of the six years, four came for tampering, the remainder for the substance in the sample. In the arithmetic of the sanction, the dominant offence is the cover-up, not the doping.

What gets annulled here is not a time but a result. The March half marathon title, its prize money, its ranking points — all void. The 2026 Tokyo win stands untouched. The record book keeps one win and deletes the win that paid for the winter.

There is an asymmetry nobody will write. The result being erased had the smallest audience; the result being kept had the largest. The punishment, though, comes from the small-audience race. It reminds me of the 2026 district final at the Barishal Divisional Stadium — 90 minutes, 400 concurrent viewers on the desk's page, 41,000 total. Small numbers, but every one of them had a name attached. The Chinese half marathon is the same shape: a tier-three label race, appearance-fee driven, its testing footprint set by the local national anti-doping organisation plus targeted AIU work rather than by commercial profile. High fee, low surveillance. Mid-tier elites live exactly there.

And the people working that gap are not doctors. The hidden cost in road running is entourage-shaped — who books the race, who takes the fee, who arranges the medical paper, who pays for it. Family is always the cheapest solution and always the most expensive error.

Here is where I get uncomfortable with the number. Six years is not a doping sentence. If the argument for removing an athlete for six years is that she deceived, then it is a sentence for document deception, not for a substance. Nobody wins a marathon on methylprednisolone. The same structure that never gave her a team doctor is now billing her six years for not having one. Both statements can be true at once, and when they are, the word justice looks correct on paper and crooked in practice.

The second discomfort points at us. We will read this as a morality tale about a foreigner, in two paragraphs, then close the file. The question is universal: where are the therapeutic use exemption files kept in our federations, who holds them, who audits them, who keeps the samples? I do not know. That not-knowing is the problem. Every transfer window is really a story about who gets believed, and so is every medical exemption.

Do the age arithmetic. Thirty-two plus six is thirty-eight. The marathon's extended peak runs roughly 27 to 33, with outliers past 35. Six years outside competition, outside testing, outside the elite training and agent ecosystem makes a return to World Marathon Major level practically nil. That is not cruelty, it is road racing's structure. Nobody regains form across a gap that size, because nobody is paid across a gap that size.

So my next spreadsheet needs another column. Today I log name, pronunciation, district, club. The new column is: who signs the paper. Which athlete has a team doctor, which does not, whose medical channel is a phone number and whose is a hospital. With that column filled, a six-year ban would never be a surprise, because the surprising fact would already be on the table.

On the 14-episode phone-recorded documentary from Kalsindur to Kathmandu I spoke to 22 players, including goalkeeper Rupna Chakma in Rangamati describing training on a paddy-field bund. No stadium, no pictures, only names and description. This case has the same architecture — no footage, no times, one name and one prescription pad.

Which makes the question small only on the surface. Next time an athlete takes six years, will we count her wins, or will we go looking for whoever wrote the paper?